scholarly article | Q13442814 |
P356 | DOI | 10.1097/00002030-200201040-00005 |
P698 | PubMed publication ID | 11741160 |
P2093 | author name string | Dawn McGuire | |
Lynn Pulliam | |||
Leonard Kusdra | |||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | neurotoxicity | Q3338704 |
toxic encephalopathy | Q7830379 | ||
macrophage | Q184204 | ||
P304 | page(s) | 31-38 | |
P577 | publication date | 2002-01-01 | |
P1433 | published in | AIDS | Q4651863 |
P1476 | title | Changes in monocyte/macrophage neurotoxicity in the era of HAART: implications for HIV-associated dementia | |
P478 | volume | 16 |
Q40483561 | Apoptotic and antiapoptotic effects of CXCR4: is it a matter of intrinsic efficacy? Implications for HIV neuropathogenesis |
Q33958988 | Association of FAK activation with lentivirus-induced disruption of blood-brain barrier tight junction-associated ZO-1 protein organization |
Q37073672 | Biomarkers of HIV related central nervous system disease |
Q35126422 | Changing patterns in the neuropathogenesis of HIV during the HAART era. |
Q39281639 | Characteristics of Activated Monocyte Phenotype Support R5-Tropic Human Immunodeficiency Virus |
Q34421694 | Cognitive impairment in older HIV-1-seropositive individuals: prevalence and potential mechanisms |
Q37122279 | Dimethyl fumarate modulation of immune and antioxidant responses: application to HIV therapy |
Q28246676 | Effects of human immunodeficiency virus type 1 on astrocyte gene expression and function: potential role in neuropathogenesis |
Q24795458 | Gene expression profile of HIV-1 Tat expressing cells: a close interplay between proliferative and differentiation signals |
Q90221085 | HIV-1 Tat: Role in Bystander Toxicity |
Q36009246 | HIV-1-related central nervous system disease: current issues in pathogenesis, diagnosis, and treatment |
Q33939729 | HIV-associated neurocognitive disorder. |
Q38809646 | HIV/neuroAIDS biomarkers. |
Q37218005 | Human immunodeficiency virus-associated dementia: clinical aspects, biology, and treatment |
Q38129638 | Is CD69 an effective brake to control inflammatory diseases? |
Q42228175 | Longitudinal analysis of activation markers on monocyte subsets during the development of simian immunodeficiency virus encephalitis |
Q45181283 | Lowest ever CD4 lymphocyte count (CD4 nadir) as a predictor of current cognitive and neurological status in human immunodeficiency virus type 1 infection--The Hawaii Aging with HIV Cohort |
Q39231455 | Maturing neurons are selectively sensitive to human immunodeficiency virus type 1 exposure in differentiating human neuroepithelial progenitor cell cultures |
Q33346244 | Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients |
Q54517758 | No reliable gene expression biomarkers of current or impending neurocognitive impairment in peripheral blood monocytes of persons living with HIV. |
Q36982959 | Osteopontin is increased in HIV-associated dementia |
Q33198613 | Proteomic fingerprinting of human immunodeficiency virus type 1-associated dementia from patient monocyte-derived macrophages: A case study |
Q35627384 | Recent clinical history and cognitive dysfunction for attention and executive function among human immunodeficiency virus-infected patients |
Q31014821 | The AIDS dementia complex: clinical and basic neuroscience with implications for novel molecular therapies |
Q36302063 | The role of monocytes and perivascular macrophages in HIV and SIV neuropathogenesis: information from non-human primate models |
Q40394829 | Up-regulation of astrocyte cyclooxygenase-2, CCAAT/enhancer-binding protein-homology protein, glucose-related protein 78, eukaryotic initiation factor 2 alpha, and c-Jun N-terminal kinase by a neurovirulent murine retrovirus |
Search more.